How to Choose the Right Home Power Backup Plan

 

There are a lot of power issues popping up on the grid, including rolling brownouts and blackouts, storms and outages. With these dangers on the horizon, it’s essential to have a backup option for your home or business.

Today, we’re taking a look at several backup energy options, like generators, solar panels and other tools. We’re going to discuss the nuances of all of them and some of the positives and some of the negatives. Giving insights to host Tyler Kern on this episode of The Next Generation of Energy by RoseWater Energy is Joe Piccirilli, CEO, RoseWater Energy.

It’s pretty obvious, but there are significant differences between generators, solar panels and
battery backups. A generator is a device used for power backup in a home and is the same type of device utility companies use to provide energy to the entire country. There is a motor that turns and puts out continuous voltage. What it can’t do is deal with a load change, so if an air conditioner gets turned on, the generator will sag. When the air conditioner gets turned off, the generator is still producing the same amount of energy, and that creates a spike.

“There is no way for a generator to anticipate that load, so it can create power anomalies through sags and surges,” Piccirilli said. “But, a generator will back up your home for as long as you have fuel, so for a long-term power backup, it is a very good option.”

Each power source has its downsides. Generators also don’t produce enough power for a home because homeowners don’t choose a device robust enough for their homes. This can be alleviated with a power conditioning device, according to Piccirilli.

Listen to hear more about the different types of power backups for the home.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More